EBMT 2019 | The intestinal microbiome for evaluating patient response to CAR T-cell therapy

Melody Smith

Melody Smith, MD, of Memorial Sloan Kettering Cancer Center, New York, NY, talks about the intestinal microbiome for predicting response in CAR T-cell therapy. Dr Smith was speaking at the European Society for Blood and Marrow Transplantation (EBMT) 2019 Annual Meeting, held in Frankfurt, Germany.

Share this video